Heart Failure Drugs Market: How Is SGLT2 Inhibitor Expansion Across...

added blog Botanik

2026-05-28 06:13:17

Heart Failure Drugs Market: How Is SGLT2 Inhibitor Expansion Across Heart Failure Types Creating Market Transformation?

SGLT2 inhibitors' heart failure market transformation — the extraordinary expansion of SGLT2 inhibitor clinical indications across the full heart failure ejection fraction spectrum — from the original diabetes-only glucose-lowering indication through HFrEF approval regardless of diabetes to HFpEF approval with empagliflozin — creating the largest single commercial expansion in...

0 Comments 0 Shares 30 Views 0 Reviews